|
🦁
|
CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinoma.
10 auth.
M. Diekstra,
J. Swen,
E. Boven,
D. Castellano,
H. Gelderblom,
R. Mathijssen,
...
C. Rodríguez‐Antona,
J. García-Donas,
B. Rini,
H. Guchelaar
|
6 |
2015 |
6
🦁
|
|
🦁
|
Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662
12 auth.
M. Diekstra,
H. Klümpen,
M. Lolkema,
Huixin Yu,
J. Kloth,
H. Gelderblom,
...
R. Schaik,
H. Gurney,
J. Swen,
A. Huitema,
N. Steeghs,
R. Mathijssen
|
6 |
2014 |
6
🦁
|
|
🦁
|
Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma
11 auth.
M. Diekstra,
Xiaoyan Liu,
J. Swen,
E. Boven,
D. Castellano,
H. Gelderblom,
...
R. Mathijssen,
C. Rodríguez‐Antona,
J. García-Donas,
B. Rini,
H. Guchelaar
|
4 |
2015 |
4
🦁
|
|
🦁
|
Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma
11 auth.
M. Diekstra,
A. Belaústegui,
J. Swen,
E. Boven,
D. Castellano,
H. Gelderblom,
...
R. Mathijssen,
J. García-Donas,
C. Rodríguez‐Antona,
B. Rini,
H. Guchelaar
|
4 |
2016 |
4
🦁
|
|
🦁
|
Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer
20 auth.
M. Diekstra,
A. Fritsch,
F. Kanefendt,
J. Swen,
D. Moes,
F. Sörgel,
M. Kinzig,
C. Stelzer,
D. Schindele,
T. Gauler,
...
S. Hauser,
D. Houtsma,
M. Roessler,
B. Moritz,
K. Mross,
L. Bergmann,
E. Oosterwijk,
L. Kiemeney,
H. Guchelaar,
U. Jaehde
|
4 |
2017 |
4
🦁
|
|
🦁
|
A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review
M. Diekstra,
J. Swen,
H. Gelderblom,
H. Guchelaar
|
4 |
2016 |
4
🦁
|
|
🐜
|
Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity.
30 auth.
Loes F. M. van der Zanden,
S. Vermeulen,
A. Óskarsdóttir,
J. S. Maurits,
M. Diekstra,
V. Ambert,
A. Cambon-Thomsen,
D. Castellano,
A. Fritsch,
J. García Donas,
R. G. Guarch Troyas,
H. Guchelaar,
A. Hartmann,
C. Hulsbergen–van de Kaa,
U. Jaehde,
...
K. Junker,
A. Martínez-Cardús,
G. Másson,
J. Oosterwijk-Wakka,
M. Radu,
T. Rafnar,
C. Rodríguez‐Antona,
M. Roessler,
R. Ruijtenbeek,
K. Stefánsson,
A. Warren,
L. Wessels,
T. Eisen,
L. Kiemeney,
E. Oosterwijk
|
4 |
2017 |
4
🐜
|
|
🐜
|
A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma
24 auth.
Xiaoyan Liu,
J. Swen,
M. Diekstra,
E. Boven,
D. Castellano,
H. Gelderblom,
R. Mathijssen,
S. Vermeulen,
E. Oosterwijk,
K. Junker,
...
M. Roessler,
K. Alexíusdóttir,
A. Sverrisdottir,
M. Radu,
V. Ambert,
T. Eisen,
A. Warren,
C. Rodríguez‐Antona,
J. García-Donas,
S. Böhringer,
K. K. Koudijs,
L. Kiemeney,
B. Rini,
H. Guchelaar
|
3 |
2018 |
3
🐜
|
